Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Jiangsu Hengrui

Jiangsu Hengrui Medicine Co.

Rank: 40

Lianyungang, Jiangsu, China
www.hrs.com.cn

2020 Revenues ($USD) : $4,017,120,014
2020 Revenues (foreign currencies) : RMB27,735,000,000
2020 R&D spend : $722,603,633
2020 Number of Employees : 28,903
Fiscal Year End : 12/31/2020
Key People : Zhou Yunshu, chair & president

Publicly traded on the Shanghai Stock Exchange, Jiangsu Hengrui Medicine boasts over 100 pipelines and products across therapeutic areas such as oncology, metabolics, autoimmune, pain management. In China, it has established a National Targeted Drug Engineering Technology Research Center. HengRui USA’s headquarters are in Princeton, N.J. –CN
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50